GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Vesting of conditional share awards under the
GlaxoSmithKline Share Value Plan
This notification sets out the vesting of an award over American Depositary Shares (ADS) in GlaxoSmithKline plc, made in 2013 under the GlaxoSmithKline Share Value Plan (SVP), which was conditional on continued employment with the GlaxoSmithKline group.
The restricted period for the 2013 SVP awards has now ended and the award made to the connected person of a Person Discharging Managerial Responsibility (PDMR) vested on 28 February 2016. Details are given in the table below.
Name of Director / PDMR |
Name of connected person |
Number of ADS vested |
Dr M Slaoui* |
Dr K Slaoui |
2,990 |
* Denotes an Executive Director
The Company and the above individual were advised of this transaction on 29 February 2016.
The closing price of an ADS of GlaxoSmithKline plc on 26 February 2015, the business day prior to vesting, was US$39.14.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
V A Whyte
Company Secretary
1 March 2016